Javascript must be enabled to use this form.

View Profile	Home Browse Faculty Facility Research Consortia Training Grants Courses Search Support About rSp Help and FAQ's Contact Us	GCC Home
Faculty Profile Last Modified Time: 10:55:18 AM Fri, 27 Mar 2020   Contact Information Filippo Giancotti Associated Profiles  Olla S. Stribling Distinguished Chair, Cancer Research, Professor, Cancer Biology, UT MD Anderson Cancer Center   MDA 3SCR5.3640 (Unit 1906)    fggiancotti@mdanderson.org     713.745.7833    Web Link    Lab Webpage    Integrins, Neurofibromin 2, Hemidesmosomes, Neoplasms, Fibronectins, Integrin alpha5beta1, Cytoskeleton, Carcinogenesis    Associated Profiles Professional Preparation Research and Expertise Affiliations Appointments  Professional Preparation  Degree Major Institution Year  PhD Cell Biology University of Torino, School of Medicine 1988  MD Medicine University of Torino, School of Medicine 1981  Research and Expertise Research Interests   Dominant mutations in oncogenes and recessive mutations in tumor suppressor genes disrupt the regulatory circuits that govern cells, endowing them with the ability to survive, proliferate, and invade independently of contextual constrains. Our laboratory studies the molecular basis of tumor initiation and progression to metastasis with emphasis on the role of adhesion signaling in these processes. We are currently examining four inter-related topics: 1) We are using mouse genetics and biochemistry to study the role of integrins — cell-matrix adhesion receptors — in tumor progression and metastasis. Our results indicate that integrin signals govern the self-renewal and invasive capacity of cancer stem cells. 2) We are studying the mechanisms by which the cadherins — cell-to-cell adhesion receptors — suppress cell proliferation. We have identified the tumor suppressor Merlin/NF2 as a critical mediator of contact inhibition of growth and demonstrated that inhibits cell proliferation by inhibiting the E3 ubiquitin ligase CRL4-DCAF1 in the nucleus. 3) We are studying the role of the Epithelial-to-Mesenchymal Transformation (EMT) and the reverse process (MET) in self-renewal and metastatic colonization. 4) Early dissemination of tumor cells followed by an extended period of proliferative quiescence is thought to explain late relapse in breast cancer and other cancers. We are using forward genetic screens in the mouse to identify the signaling, transcriptional, and epigenetic mechanisms that govern metastatic dormancy and reactivation in breast, prostate, and pancreatic cancer. By delineating new mechanisms underlying tumor initiation and progression to metastasis, we hope to identify novel targets for therapeutic intervention.  Publications/Creative Works Click here to search for this faculty member's publications on PubMed.  Affiliations  Research Consortia Gulf Coast Cluster for Single Cell Omics  Appointments Title Department / School Institution Olla S. Stribling Distinguished Chair Cancer Research UT MD Anderson Cancer Center

powering - The Partnership
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.